8-K current report · filed Jul 1, 2026

Inogen Inc (INGN) 8-K Current Report: July 1, 2026

Item 5.02Item 7.01Item EX-99.1INGN overview

Short answer

Inogen Inc (INGN) filed an 8-K current report with the SEC on July 1, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Andy Reding appointed Executive Vice President and COO effective July 6, 2026, adding medical-device commercial and operations leadership.

Inogen Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Andy Reding appointed Executive Vice President and COO effective July 6, 2026, adding medical-device commercial and operations leadership
  • Annual base salary $500,000 with target performance bonus opportunity equal to 70% of salary
  • $100,000 sign-on bonus plus inducement RSUs covering 130,000 shares, vesting one-third annually over three years
  • Severance: 12 months’ salary generally, extending to 24 months following qualifying termination during the change-of-control period
  • Nasdaq Rule 5635(c)(4) permits the 130,000-share inducement award without shareholder approval

Item 7.01 · Regulation FD Disclosure

  • New Chief Operating Officer appointment announced July 1, 2026
  • Leadership change may affect operating execution and strategic priorities
  • Exhibit 99.1 contains the appointment press release and related details

Item EX-99.1 · Exhibit EX-99.1

  • Andy Reding appointed Chief Operating Officer effective July 6, 2026, creating a new senior operating role
  • COO mandate covers revenue growth, operational performance, cross-functional execution, and global expansion
  • Reding brings 30-plus years in medical technology and prior respiratory-care leadership at Hillrom Respiratory Health
  • Inducement award covers 130,000 RSUs, vesting one-third annually over three years subject to continued service
  • Appointment signals execution focus around product launches, geographic expansion, profitability, and innovation pipeline

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Inogen Inc 8-K filings

Get the next INGN 8-K as it lands

Follow INGN for push alerts, or ask the research agent what this filing means.